📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survival. (2019)

First Author: Cortes E

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/embr.201846557

PubMed Identifier: 30538116

Publication URI: http://europepmc.org/abstract/MED/30538116

Type: Journal Article/Review

Volume: 20

Parent Publication: EMBO reports

Issue: 1

ISSN: 1469-221X